SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Themis Medicare - Quaterly Results

14 Feb 2025 Evaluate
A fair growth of 13.69% in the revenue at Rs. 938.06 millions was reported in the December 2024 quarter as compared to Rs. 825.13 millions during year-ago period.Profit for the quarter ended December 2024 rises by 53.97% to Rs. 30.81  millions from Rs. 20.01 millions.OP of the company witnessed a marginal growth to 95.50 millions from 86.33 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202412 202312 % Var 202412 202312 % Var 202403 202303 % Var
Sales 938.06 825.13 13.69 2994.75 2253.86 32.87 3817.61 3543.23 7.74
Other Income 10.22 5.65 80.88 25.00 34.09 -26.66 47.56 115.05 -58.66
PBIDT 95.50 86.33 10.62 572.95 261.78 118.87 562.89 789.67 -28.72
Interest 27.88 26.85 3.84 58.24 61.85 -5.84 93.76 95.64 -1.97
PBDT 67.62 59.48 13.69 514.71 199.93 157.45 469.13 694.03 -32.40
Depreciation 25.40 30.96 -17.96 46.12 52.41 -12.00 122.46 104.95 16.68
PBT 42.22 28.52 48.04 468.59 147.52 217.65 346.67 589.08 -41.15
TAX 11.41 8.51 34.08 122.83 41.10 198.86 99.20 156.14 -36.47
Deferred Tax -0.09 1.01 -108.91 5.04 3.64 38.46 7.00 6.14 14.01
PAT 30.81 20.01 53.97 345.76 106.42 224.90 247.47 432.94 -42.84
Equity 92.04 92.03 0.01 92.04 92.03 0.01 92.04 92.03 0.01
PBIDTM(%) 10.18 10.46 -2.70 19.13 11.61 64.72 14.74 22.29 -33.84

Themis Medicare Share Price

90.25 4.97 (5.83%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×